EmendoBio: Emendo Biotherapeutics to Present New Data at 63rd ASH Annual Meeting & Exhibition

Emendo Biotherapeutics, a next-generation CRISPR company expanding the reach of gene editing therapeutics, will be presenting a poster at the annual American Society of Hematology conference in Atlanta, taking place December 11-14, 2021.